Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 311

1.

[SR-B1: an active transporter of LDL through the endothelium].

Tedgui A.

Med Sci (Paris). 2019 Aug-Sep;35(8-9):632-634. doi: 10.1051/medsci/2019123. Epub 2019 Sep 18. French. No abstract available.

PMID:
31532374
2.

Allograft inflammatory factor-1, a multi-target regulator of atherosclerosis.

Zhang Y, Tedgui A, Ait-Oufella H.

Atherosclerosis. 2019 Oct;289:179-180. doi: 10.1016/j.atherosclerosis.2019.08.008. Epub 2019 Aug 23. No abstract available.

PMID:
31477235
3.

Anticytokine Immune Therapy and Atherothrombotic Cardiovascular Risk.

Ait-Oufella H, Libby P, Tedgui A.

Arterioscler Thromb Vasc Biol. 2019 Aug;39(8):1510-1519. doi: 10.1161/ATVBAHA.119.311998. Epub 2019 Jul 11.

PMID:
31294625
4.

Adaptive Immune Responses Contribute to Post-ischemic Cardiac Remodeling.

Santos-Zas I, Lemarié J, Tedgui A, Ait-Oufella H.

Front Cardiovasc Med. 2019 Jan 10;5:198. doi: 10.3389/fcvm.2018.00198. eCollection 2018. Review.

5.

MicroRNA-21 Deficiency Alters the Survival of Ly-6Clo Monocytes in ApoE-/- Mice and Reduces Early-Stage Atherosclerosis-Brief Report.

Chipont A, Esposito B, Challier I, Montabord M, Tedgui A, Mallat Z, Loyer X, Potteaux S.

Arterioscler Thromb Vasc Biol. 2019 Feb;39(2):170-177. doi: 10.1161/ATVBAHA.118.311942.

PMID:
30587001
6.

Cholesterol controversy: considerations for mouse models of atherosclerosis.

Tedgui A.

Cardiovasc Res. 2018 Dec 1;114(14):1907. doi: 10.1093/cvr/cvy269. No abstract available.

PMID:
30445558
7.

Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health.

Laurans L, Venteclef N, Haddad Y, Chajadine M, Alzaid F, Metghalchi S, Sovran B, Denis RGP, Dairou J, Cardellini M, Moreno-Navarrete JM, Straub M, Jegou S, McQuitty C, Viel T, Esposito B, Tavitian B, Callebert J, Luquet SH, Federici M, Fernandez-Real JM, Burcelin R, Launay JM, Tedgui A, Mallat Z, Sokol H, Taleb S.

Nat Med. 2018 Aug;24(8):1113-1120. doi: 10.1038/s41591-018-0060-4. Epub 2018 Jun 25.

PMID:
29942089
8.

Cardiovascular Research in France.

Boulanger CM, Silvestre JS, Tedgui A.

Circ Res. 2018 Mar 2;122(5):657-660. doi: 10.1161/CIRCRESAHA.117.310841. No abstract available.

9.

Indoleamine 2 3-dioxygenase knockout limits angiotensin II-induced aneurysm in low density lipoprotein receptor-deficient mice fed with high fat diet.

Metghalchi S, Vandestienne M, Haddad Y, Esposito B, Dairou J, Tedgui A, Mallat Z, Potteaux S, Taleb S.

PLoS One. 2018 Mar 1;13(3):e0193737. doi: 10.1371/journal.pone.0193737. eCollection 2018.

10.

Selective EGF-Receptor Inhibition in CD4+ T Cells Induces Anergy and Limits Atherosclerosis.

Zeboudj L, Maître M, Guyonnet L, Laurans L, Joffre J, Lemarie J, Bourcier S, Nour-Eldine W, Guérin C, Friard J, Wakkach A, Fabre E, Tedgui A, Mallat Z, Tharaux PL, Ait-Oufella H.

J Am Coll Cardiol. 2018 Jan 16;71(2):160-172. doi: 10.1016/j.jacc.2017.10.084.

11.

IL-17 in atherosclerosis: the good and the bad.

Taleb S, Tedgui A.

Cardiovasc Res. 2018 Jan 1;114(1):7-9. doi: 10.1093/cvr/cvx225. No abstract available.

PMID:
29228116
12.

Selective EGFR (Epidermal Growth Factor Receptor) Deletion in Myeloid Cells Limits Atherosclerosis-Brief Report.

Zeboudj L, Giraud A, Guyonnet L, Zhang Y, Laurans L, Esposito B, Vilar J, Chipont A, Papac-Milicevic N, Binder CJ, Tedgui A, Mallat Z, Tharaux PL, Ait-Oufella H.

Arterioscler Thromb Vasc Biol. 2018 Jan;38(1):114-119. doi: 10.1161/ATVBAHA.117.309927. Epub 2017 Nov 30.

PMID:
29191921
13.

Genetic and pharmacological inhibition of microRNA-92a maintains podocyte cell cycle quiescence and limits crescentic glomerulonephritis.

Henique C, Bollée G, Loyer X, Grahammer F, Dhaun N, Camus M, Vernerey J, Guyonnet L, Gaillard F, Lazareth H, Meyer C, Bensaada I, Legrès L, Satoh T, Akira S, Bruneval P, Dimmeler S, Tedgui A, Karras A, Thervet E, Nochy D, Huber TB, Mesnard L, Lenoir O, Tharaux PL.

Nat Commun. 2017 Nov 28;8(1):1829. doi: 10.1038/s41467-017-01885-7.

14.

Endothelial autophagic flux hampers atherosclerotic lesion development.

Kheloufi M, Vion AC, Hammoutene A, Poisson J, Lasselin J, Devue C, Pic I, Dupont N, Busse J, Stark K, Lafaurie-Janvore J, Barakat AI, Loyer X, Souyri M, Viollet B, Julia P, Tedgui A, Codogno P, Boulanger CM, Rautou PE.

Autophagy. 2018;14(1):173-175. doi: 10.1080/15548627.2017.1395114. Epub 2018 Jan 29.

15.

Genetic Depletion or Hyperresponsiveness of Natural Killer Cells Do Not Affect Atherosclerosis Development.

Nour-Eldine W, Joffre J, Zibara K, Esposito B, Giraud A, Zeboudj L, Vilar J, Terada M, Bruneval P, Vivier E, Ait-Oufella H, Mallat Z, Ugolini S, Tedgui A.

Circ Res. 2018 Jan 5;122(1):47-57. doi: 10.1161/CIRCRESAHA.117.311743. Epub 2017 Oct 18.

PMID:
29046274
16.

Autophagy is required for endothelial cell alignment and atheroprotection under physiological blood flow.

Vion AC, Kheloufi M, Hammoutene A, Poisson J, Lasselin J, Devue C, Pic I, Dupont N, Busse J, Stark K, Lafaurie-Janvore J, Barakat AI, Loyer X, Souyri M, Viollet B, Julia P, Tedgui A, Codogno P, Boulanger CM, Rautou PE.

Proc Natl Acad Sci U S A. 2017 Oct 10;114(41):E8675-E8684. doi: 10.1073/pnas.1702223114. Epub 2017 Sep 25.

17.

Angiotensin II synergizes with BAFF to promote atheroprotective regulatory B cells.

Ponnuswamy P, Joffre J, Herbin O, Esposito B, Laurans L, Binder CJ, Tedder TF, Zeboudj L, Loyer X, Giraud A, Zhang Y, Tedgui A, Mallat Z, Ait-Oufella H.

Sci Rep. 2017 Jun 23;7(1):4111. doi: 10.1038/s41598-017-04438-6.

18.

The Dendritic Cell Receptor DNGR-1 Promotes the Development of Atherosclerosis in Mice.

Haddad Y, Lahoute C, Clément M, Laurans L, Metghalchi S, Zeboudj L, Giraud A, Loyer X, Vandestienne M, Wain-Hobson J, Esposito B, Potteaux S, Ait-Oufella H, Tedgui A, Mallat Z, Taleb S.

Circ Res. 2017 Jul 21;121(3):234-243. doi: 10.1161/CIRCRESAHA.117.310960. Epub 2017 Jun 12.

PMID:
28607102
19.

Gingival fibroblasts protect against experimental abdominal aortic aneurysm development and rupture through tissue inhibitor of metalloproteinase-1 production.

Giraud A, Zeboudj L, Vandestienne M, Joffre J, Esposito B, Potteaux S, Vilar J, Cabuzu D, Kluwe J, Seguier S, Tedgui A, Mallat Z, Lafont A, Ait-Oufella H.

Cardiovasc Res. 2017 Sep 1;113(11):1364-1375. doi: 10.1093/cvr/cvx110.

PMID:
28582477
20.

The Pathogenic Transforming Growth Factor-β Overdrive Hypothesis in Aortic Aneurysms and Dissections: A Mirage?

Mallat Z, Ait-Oufella H, Tedgui A.

Circ Res. 2017 May 26;120(11):1718-1720. doi: 10.1161/CIRCRESAHA.116.310371. Review. No abstract available.

21.

Genetic and Pharmacological Inhibition of TREM-1 Limits the Development of Experimental Atherosclerosis.

Joffre J, Potteaux S, Zeboudj L, Loyer X, Boufenzer A, Laurans L, Esposito B, Vandestienne M, de Jager SC, Hénique C, Zlatanova I, Taleb S, Bruneval P, Tedgui A, Mallat Z, Gibot S, Ait-Oufella H.

J Am Coll Cardiol. 2016 Dec 27;68(25):2776-2793. doi: 10.1016/j.jacc.2016.10.015.

22.

Role of Microvascular Tone and Extracellular Matrix Contraction in the Regulation of Interstitial Fluid: Implications for Aortic Dissection.

Mallat Z, Tedgui A, Henrion D.

Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):1742-7. doi: 10.1161/ATVBAHA.116.307909. Epub 2016 Jul 21. Review.

PMID:
27444198
23.

Regulatory T-Cell Plasticity: Another Layer of Complexity in Atherosclerosis.

Ait-Oufella H, Tedgui A.

Circ Res. 2016 May 13;118(10):1461-3. doi: 10.1161/CIRCRESAHA.116.308805. No abstract available.

24.

Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression.

Loyer X, Paradis V, Hénique C, Vion AC, Colnot N, Guerin CL, Devue C, On S, Scetbun J, Romain M, Paul JL, Rothenberg ME, Marcellin P, Durand F, Bedossa P, Prip-Buus C, Baugé E, Staels B, Boulanger CM, Tedgui A, Rautou PE.

Gut. 2016 Nov;65(11):1882-1894. doi: 10.1136/gutjnl-2014-308883. Epub 2015 Sep 3.

25.

Monocytes, Macrophages and Other Inflammatory Mediators of Abdominal Aortic Aneurysm.

Potteaux S, Tedgui A.

Curr Pharm Des. 2015;21(28):4007-15. Review.

PMID:
26306839
26.

Periodontal microbiota and phospholipases: the Oral Infections and Vascular Disease Epidemiology Study (INVEST).

Boillot A, Demmer RT, Mallat Z, Sacco RL, Jacobs DR, Benessiano J, Tedgui A, Rundek T, Papapanou PN, Desvarieux M.

Atherosclerosis. 2015 Oct;242(2):418-23. doi: 10.1016/j.atherosclerosis.2015.07.039. Epub 2015 Jul 22.

27.

Indoleamine 2,3-Dioxygenase Fine-Tunes Immune Homeostasis in Atherosclerosis and Colitis through Repression of Interleukin-10 Production.

Metghalchi S, Ponnuswamy P, Simon T, Haddad Y, Laurans L, Clément M, Dalloz M, Romain M, Esposito B, Koropoulis V, Lamas B, Paul JL, Cottin Y, Kotti S, Bruneval P, Callebert J, den Ruijter H, Launay JM, Danchin N, Sokol H, Tedgui A, Taleb S, Mallat Z.

Cell Metab. 2015 Sep 1;22(3):460-71. doi: 10.1016/j.cmet.2015.07.004. Epub 2015 Jul 30.

28.

The intravenous injection of oxidized LDL- or Apolipoprotein B100--Coupled splenocytes promotes Th1 polarization in wildtype and Apolipoprotein E--Deficient mice.

Steinmetz M, Ponnuswamy P, Laurans L, Esposito B, Tedgui A, Mallat Z.

Biochem Biophys Res Commun. 2015 Aug 14;464(1):306-11. doi: 10.1016/j.bbrc.2015.06.148. Epub 2015 Jun 24.

PMID:
26116775
29.

Mechanosensitive PPAP2B Regulates Endothelial Responses to Atherorelevant Hemodynamic Forces.

Wu C, Huang RT, Kuo CH, Kumar S, Kim CW, Lin YC, Chen YJ, Birukova A, Birukov KG, Dulin NO, Civelek M, Lusis AJ, Loyer X, Tedgui A, Dai G, Jo H, Fang Y.

Circ Res. 2015 Jul 31;117(4):e41-e53. doi: 10.1161/CIRCRESAHA.117.306457. Epub 2015 Jun 1.

30.

IL-9: a new culprit in atherosclerosis?

Taleb S, Tedgui A.

Cardiovasc Res. 2015 Jun 1;106(3):348-50. doi: 10.1093/cvr/cvv134. Epub 2015 Apr 23. No abstract available.

PMID:
25908649
31.

Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease.

Camus SM, De Moraes JA, Bonnin P, Abbyad P, Le Jeune S, Lionnet F, Loufrani L, Grimaud L, Lambry JC, Charue D, Kiger L, Renard JM, Larroque C, Le Clésiau H, Tedgui A, Bruneval P, Barja-Fidalgo C, Alexandrou A, Tharaux PL, Boulanger CM, Blanc-Brude OP.

Blood. 2015 Jun 11;125(24):3805-14. doi: 10.1182/blood-2014-07-589283. Epub 2015 Mar 31.

32.

Atenolol versus Losartan in Marfan's Syndrome.

Mallat Z, Tedgui A.

N Engl J Med. 2015 Mar 5;372(10):980. doi: 10.1056/NEJMc1500128. No abstract available.

PMID:
25738683
33.

Atheroprotective immunity and cardiovascular disease: therapeutic opportunities and challenges.

Nilsson J, Lichtman A, Tedgui A.

J Intern Med. 2015 Nov;278(5):507-19. doi: 10.1111/joim.12353.

34.

Dissecting abdominal aortic aneurysm in Ang II-infused mice: suprarenal branch ruptures and apparent luminal dilatation.

Trachet B, Fraga-Silva RA, Piersigilli A, Tedgui A, Sordet-Dessimoz J, Astolfo A, Van der Donckt C, Modregger P, Stampanoni MF, Segers P, Stergiopulos N.

Cardiovasc Res. 2015 Feb 1;105(2):213-22. doi: 10.1093/cvr/cvu257. Epub 2014 Dec 23.

35.

Angiotensin II mobilizes spleen monocytes to promote the development of abdominal aortic aneurysm in Apoe-/- mice.

Mellak S, Ait-Oufella H, Esposito B, Loyer X, Poirier M, Tedder TF, Tedgui A, Mallat Z, Potteaux S.

Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):378-88. doi: 10.1161/ATVBAHA.114.304389. Epub 2014 Dec 18.

PMID:
25524776
36.

Alain Tedgui: atherosclerosis research à la Française.

Tedgui A, Williams R.

Circ Res. 2014 Dec 5;115(12):973-5. doi: 10.1161/CIRCRESAHA.114.305565. No abstract available.

PMID:
25477485
37.

MicroRNAs as therapeutic targets in atherosclerosis.

Loyer X, Mallat Z, Boulanger CM, Tedgui A.

Expert Opin Ther Targets. 2015 Apr;19(4):489-96. doi: 10.1517/14728222.2014.989835. Epub 2014 Dec 3. Review.

PMID:
25464904
38.

IL-17 and Th17 cells in atherosclerosis: subtle and contextual roles.

Taleb S, Tedgui A, Mallat Z.

Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):258-64. doi: 10.1161/ATVBAHA.114.303567. Epub 2014 Sep 18. Review.

PMID:
25234818
39.

[Lp-PLA2 and sPLA2: cardiovascular biomarkers].

Ait-Oufella H, Mallat Z, Tedgui A.

Med Sci (Paris). 2014 May;30(5):526-31. doi: 10.1051/medsci/20143005015. Epub 2014 Jun 13. Review. French.

40.

Microparticles and sudden cardiac death due to coronary occlusion. The TIDE (Thrombus and Inflammation in sudden DEath) study.

Empana JP, Boulanger CM, Tafflet M, Renard JM, Leroyer AS, Varenne O, Prugger C, Silvain J, Tedgui A, Cariou A, Montalescot G, Jouven X, Spaulding C.

Eur Heart J Acute Cardiovasc Care. 2015 Feb;4(1):28-36. doi: 10.1177/2048872614538404. Epub 2014 Jun 9.

PMID:
24912925
41.

Adaptive (T and B cells) immunity and control by dendritic cells in atherosclerosis.

Ait-Oufella H, Sage AP, Mallat Z, Tedgui A.

Circ Res. 2014 May 9;114(10):1640-60. doi: 10.1161/CIRCRESAHA.114.302761. Review.

PMID:
24812352
42.

Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study.

Amabile N, Cheng S, Renard JM, Larson MG, Ghorbani A, McCabe E, Griffin G, Guerin C, Ho JE, Shaw SY, Cohen KS, Vasan RS, Tedgui A, Boulanger CM, Wang TJ.

Eur Heart J. 2014 Nov 7;35(42):2972-9. doi: 10.1093/eurheartj/ehu153. Epub 2014 Apr 16.

43.

Microvesicles as cell-cell messengers in cardiovascular diseases.

Loyer X, Vion AC, Tedgui A, Boulanger CM.

Circ Res. 2014 Jan 17;114(2):345-53. doi: 10.1161/CIRCRESAHA.113.300858. Review.

PMID:
24436430
44.

Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice.

Loyer X, Potteaux S, Vion AC, Guérin CL, Boulkroun S, Rautou PE, Ramkhelawon B, Esposito B, Dalloz M, Paul JL, Julia P, Maccario J, Boulanger CM, Mallat Z, Tedgui A.

Circ Res. 2014 Jan 31;114(3):434-43. doi: 10.1161/CIRCRESAHA.114.302213. Epub 2013 Nov 19.

PMID:
24255059
45.

Innate lymphoid cells: new players in atherosclerosis?

Tedgui A, Ait-Oufella H.

Arterioscler Thromb Vasc Biol. 2013 Dec;33(12):2697-8. doi: 10.1161/ATVBAHA.113.302607. No abstract available.

PMID:
24226956
46.

Infection duration and inflammatory imbalance are associated with atherosclerotic risk in HIV-infected never-smokers independent of antiretroviral therapy.

Desvarieux M, Boccara F, Meynard JL, Bastard JP, Mallat Z, Charbit B, Demmer RT, Haddour N, Fellahi S, Tedgui A, Cohen A, Capeau J, Boyd A, Girard PM.

AIDS. 2013 Oct 23;27(16):2603-14. doi: 10.1097/QAD.0b013e3283634819.

PMID:
24100713
47.

B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction.

Zouggari Y, Ait-Oufella H, Bonnin P, Simon T, Sage AP, Guérin C, Vilar J, Caligiuri G, Tsiantoulas D, Laurans L, Dumeau E, Kotti S, Bruneval P, Charo IF, Binder CJ, Danchin N, Tedgui A, Tedder TF, Silvestre JS, Mallat Z.

Nat Med. 2013 Oct;19(10):1273-80. doi: 10.1038/nm.3284. Epub 2013 Sep 15.

48.

Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study.

Holmes MV, Simon T, Exeter HJ, Folkersen L, Asselbergs FW, Guardiola M, Cooper JA, Palmen J, Hubacek JA, Carruthers KF, Horne BD, Brunisholz KD, Mega JL, van Iperen EPA, Li M, Leusink M, Trompet S, Verschuren JJW, Hovingh GK, Dehghan A, Nelson CP, Kotti S, Danchin N, Scholz M, Haase CL, Rothenbacher D, Swerdlow DI, Kuchenbaecker KB, Staines-Urias E, Goel A, van 't Hooft F, Gertow K, de Faire U, Panayiotou AG, Tremoli E, Baldassarre D, Veglia F, Holdt LM, Beutner F, Gansevoort RT, Navis GJ, Mateo Leach I, Breitling LP, Brenner H, Thiery J, Dallmeier D, Franco-Cereceda A, Boer JMA, Stephens JW, Hofker MH, Tedgui A, Hofman A, Uitterlinden AG, Adamkova V, Pitha J, Onland-Moret NC, Cramer MJ, Nathoe HM, Spiering W, Klungel OH, Kumari M, Whincup PH, Morrow DA, Braund PS, Hall AS, Olsson AG, Doevendans PA, Trip MD, Tobin MD, Hamsten A, Watkins H, Koenig W, Nicolaides AN, Teupser D, Day INM, Carlquist JF, Gaunt TR, Ford I, Sattar N, Tsimikas S, Schwartz GG, Lawlor DA, Morris RW, Sandhu MS, Poledne R, Maitland-van der Zee AH, Khaw KT, Keating BJ, van der Harst P, Price JF, Mehta SR, Yusuf S, Witteman JCM, Franco OH, Jukema JW, de Knijff P, Tybjaerg-Hansen A, Rader DJ, Farrall M, Samani NJ, Kivimaki M, Fox KAA, Humphries SE, Anderson JL, Boekholdt SM, Palmer TM, Eriksson P, Paré G, Hingorani AD, Sabatine MS, Mallat Z, Casas JP, Talmud PJ.

J Am Coll Cardiol. 2013 Nov 19;62(21):1966-1976. doi: 10.1016/j.jacc.2013.06.044. Epub 2013 Jul 31.

49.

Natural regulatory T cells limit angiotensin II-induced aneurysm formation and rupture in mice.

Ait-Oufella H, Wang Y, Herbin O, Bourcier S, Potteaux S, Joffre J, Loyer X, Ponnuswamy P, Esposito B, Dalloz M, Laurans L, Tedgui A, Mallat Z.

Arterioscler Thromb Vasc Biol. 2013 Oct;33(10):2374-9. doi: 10.1161/ATVBAHA.113.301280. Epub 2013 Aug 1.

PMID:
23908246
50.

Shear stress regulates endothelial microparticle release.

Vion AC, Ramkhelawon B, Loyer X, Chironi G, Devue C, Loirand G, Tedgui A, Lehoux S, Boulanger CM.

Circ Res. 2013 May 10;112(10):1323-33. doi: 10.1161/CIRCRESAHA.112.300818. Epub 2013 Mar 27.

PMID:
23536307

Supplemental Content

Loading ...
Support Center